Monzr M. Al Malki, MD¹, Alla Keyzner, MD², Hyung Chan Suh, MD, PhD³, Aasiya Matin, MD⁴, Erica Buonomo, PhD^5*, Yun Wang, PhD^5*, Nina Abelowitz, ANP^5*, Jim Murray^5*, Gavin Macbeath, PhD^5*, Debora Barton, MD^5*, Shrikanta Chattopadhyay, MD⁵ and Ran Reshef, MD, MSc⁶

¹Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
²Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
³Hackensack University Medical Center, Hackensack, NJ
⁴Karmanos Cancer Institute/Wayne State University, Detroit, MI
⁵TScan Therapeutics, Waltham, MA
⁶Blood and Marrow Stem Cell Transplantation Program, Division of Hematology & Oncology, Columbia University Irving Medical Center, New York, NY

Anne Marijn Kramer, MD, PhD^1,2,3*, Mark P. Hamilton, MD⁴, Snehit Prabhu, PhD^2*, Moksha Desai^2*, Adam Kuo, MS^5*, Zachary Ehlinger^2*, Neha Agarwal, MS^4*, Yi-Jiun Su, MD^6*, Nikolaos Gkitsas, MSc, BSc^2*, Carley Fowler, MS^2*, Vimal Keerthi^2*, Aidan Retherford^2*, Dorota Klysz, PhD^2*, Ramya Tunuguntla, PhD^2*, Steven Feldman, PhD^2*, Bita Sahaf, PhD, MSc^7*, John H. Baird, MD⁸, Lori S. Muffly, MD⁹, Crystal L. Mackall, MD⁵, David B. Miklos, MD, PhD^5,10, Zinaida Good, PhD^2,6 and Matthew J. Frank, MD, PhD^5,10

¹Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Menlo Park, CA
²Center for Cancer Cell Therapy, Stanford University, Stanford, CA
³Cancer Center Amsterdam, Department of Hematology, Amsterdam UMC, Amsterdam, Netherlands
⁴Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
⁵Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA
⁶Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Palo Alto, CA
⁷Cancer Correlative Science Unit, Stanford University, Palo Alto, CA
⁸Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA
⁹Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA
¹⁰Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA

Charles Yin, MD, PhD¹, Bindu Thapa^2*, Carina Debes-Marun^2*, Zack Breckenridge, BSc^3*, Irwindeep Sandhu⁴, Faisal Khan, PhD^5* and Michael P. Chu, MD⁶

¹University of Alberta, Edmonton, AB, Canada
²University of Alberta, Edmonton, Canada
³University of Calgary, Calgary, Canada
⁴Cross Cancer Institute, Edmonton, AB, Canada
⁵Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, CAN
⁶Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada

Emma Searle, MD^1,2*, Liam Tremble, PhD, MSc, BSc^3*, Rakesh Popat^4,5,6*, Digna de Bruin, MD. PhD.^7,8*, Matthijs Moerland, PhD.^7,8* and Brendan Buckley, Prof. MD.^3*

¹The University of Manchester, Manchester, United Kingdom
²The Christie NHS Foundation Trust, Manchester, United Kingdom
³Poolbeg Pharma, Dublin, Ireland
⁴Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁵NIHR UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁶University College London, London, United Kingdom
⁷Centre for Human Drug Research (CHDR),, Leiden, Netherlands
⁸Leiden University Medical Center (LUMC), Leiden, Netherlands

Xibin Xiao^1*, Wen Lei^1*, Huawei Jiang^1*, Xi Qiu^1*, Xian Li^1*, Panpan Chen^1*, Yang Xu^1*, Haicun Xie^2*, Guangrong Song^2*, Yu Cheng^2*, Fuqiang Wu^2*, Daqing Liu^2*, Liming Yang^2* and Wenbin Qian^1*

¹The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
²WYZE Biotech Co., Ltd, Zhongshan, China

Frederick L. Locke, MD¹, Javier L. Munoz², Michael T. Tees, MD³, Lazaros J. Lekakis^4*, Herbert A. Eradat, MD⁵, Sven de Vos, MD, PhD^5*, Rajneesh Nath^6*, Don A. Stevens, MD⁷, Shahbaz A. Malik, MD⁸, Geoffrey P. Shouse, PhD, DO⁹, Mehdi Hamadani, MD¹⁰, Olalekan O. Oluwole, MBBS¹¹, Miguel-Angel Perales, MD¹², David B. Miklos, MD, PhD¹³, Anh Nguyen^14*, Amy Feng^14*, Lynn Navale^14*, Elaine Murray^14*, Greg P. Kaufman^14*, Kazuharu Kai^14*, John B. Le Gall^14* and Sattva S. Neelapu, MD¹⁵

¹H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²Mayo Clinic, Scottsdale, AZ
³The Colorado Blood Cancer Institute a part of Sarah Cannon Cancer Institute at Presbyterian/St Luke's Medical Center, Denver, CO
⁴University of Miami, Miami, FL
⁵Department of Medicine/Division of Hematology and Oncology, UCLA Medical Center, Los Angeles, CA
⁶Banner MD Anderson Cancer Center, Scottsdale, AZ
⁷Norton Cancer Institute, Louisville, KY
⁸St. David's South Austin Medical Center, Austin, TX
⁹Hematology/HCT, City of Hope National Medical Center, Duarte, CA
¹⁰Division of Hematology and Oncology, The Medical College of Wisconsin Inc, Milwaukee, WI
¹¹Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
¹²Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹³Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
¹⁴Allogene Therapeutics, San Francisco, CA
¹⁵Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Yunlin Zhang, MS^1*, Ruchi P. Patel, MS¹, Ki Hyun Kim^2*, Hyungwoo Cho, MD^3*, Jae-Cheol Cho^4*, Seong Hyun Jeong, MD^5*, Sung Yong Oh, MD^6*, Yoon Seok Choi, MD, PhD⁷, Sung-Hyun Kim, MD^6*, Ji Hyun Lee, MD, PhD⁶, Mathew G. Angelos, MD, PhD^1,8, Puneeth Guruprasad^9*, Ivan J Cohen, PhD^1*, Ositadimma Ugwuanyi, BS^1*, Yong Gu Lee, PhD^1*, Raymone Pajarillo, MS^1*, Jong Hyun Cho^10*, Alberto Carturan, MD^1*, Luca Paruzzo, MD^1*, Guido Ghilardi, MD^1*, Soohwan Kim^2*, Sung Min Kim^2*, Hyun Jong Lee^2*, Ji Ho Park^2*, Lei Guang Cui^2*, Tae Bum Lee^2*, Insik Hwang, MS^2*, Youngha Lee^2*, Yong-Jun Lee^2*, Patrizia Porazzi, PhD^11*, Dongfang Liu^10*, Yoon Lee^2*, Jong Hoon Kim^2*, Jong Seo Lee^2*, Dok Hyun Yoon, MD, PhD^3*, Junho Chung^12* and Marco Ruella, MD^1,13

¹Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
²Biopharmaceutical Research Center, AbClon Inc., Seoul, Korea, Republic of (South)
³Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁴Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea, Republic of (South)
⁵Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea, Republic of (South)
⁶Dong-A University Hospital, Busan, Korea, Republic of (South)
⁷Ajou University School of Medicine, Suwon, Korea, Republic of (South)
⁸Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, PA
⁹Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, North Wales, PA
¹⁰Department of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical School, Camden, NJ
¹¹Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
¹²Seoul National University College of Medicine, Seoul, KOR
¹³Department of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA

Craig S Sauter, MD¹, Gautam Borthakur, MD², Luke Mountjoy, DO³, Marcello Rotta, MD^3*, Hongtao Liu, MD, PhD⁴, Hemant S. Murthy, MD⁵, Ming Lin, PhD^6*, James Trager, Ph.D^6*, Cornell Chang^6*, Nishi Kothari, MD^6*, David Shook, MD⁶ and Carlos Bachier, MD⁷

¹Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Colorado Blood Cancer Institute, Denver, CO
⁴University of Wisconsin-Madison, Madison, WI
⁵Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
⁶Nkarta, South San Francisco, CA
⁷Sarah Cannon Transplant and Cellular Therapy Program at Methodist Hospital, San Antonio, TX

James McCloskey, MD¹, Hongtao Liu, MD, PhD², Daniel N. Egan, MD³, Jesus G. Berdeja, MD⁴, Stephanie B. Tsai, MD, MS⁵, Adrian Kilcoyne, MD^6*, Cherie Daly^7*, Sharmila Koppisetti^8*, Ramji Krishnan, PhD^9*, Robert Hariri, MD, PhD^10* and Eunice S Wang, MD¹¹

¹The John Theurer Cancer Center at Hackensack Meridian Health, Hackensack, NJ
²University of Wisconsin-Madison, Madison, WI
³Swedish Center for Blood Disorders and Stem Cell Transplants, Seattle, WA
⁴Sarah Cannon Center For Blood Cancers, Nashville, TN
⁵Loyola University Health System, Maywood, IL
⁶Celularity, Florham Park, NJ
⁷Celularity Inc, Warren, NJ
⁸Celularity Inc., Florham Park, NJ
⁹Celularity, Florham Park
¹⁰Celularity, florham park, NJ
¹¹Department of Medicine, Roswell Park Comprehensive Cancer Center, BUFFALO, NY

Rocio Montes de Oca^1*, Junchen Gu^1*, Hao Zhao^1*, Kathy Zelinsky^1*, Dianna Wu^1*, Cuc Davis^1*, Jaymala Patel^1*, Brad Foulk^1*, Rengasamy Boominathan^1*, Onsay Lau^1*, Denis Smirnov^1*, Yi Lin, MD, PhD², Sundar Jagannath^3*, Adam D. Cohen, MD⁴, Nahor Haddish-Berhane^5*, Jean Xu^1*, Deepu Madduri^6*, An-Sofie Stevens^7*, Carolyn Chang Jackson⁶, Jordan M. Schecter⁶, Arnob Banerjee^1*, Dong Geng^8*, Jieqing Zhu^8*, Sifan Xu^8* and Enrique Zudaire^1*

¹Janssen Research & Development, Spring House, PA
²Mayo Clinic Cancer Center, Rochester, MN
³Mount Sinai Medical Center, New York, NY
⁴Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
⁵Janssen Research & Development, LLC, Spring House, PA
⁶Janssen Research & Development, Raritan, NJ
⁷Janssen Research & Development, Beerse, BEL
⁸Legend Biotech USA Inc., Somerset, NJ

Wenyi Lu, PhD^1,2*, Meng Zhang^2*, Hairong Lv^2*, Xia Xiao, MD^2*, Xue Bai^2*, Jiaxi Wang^2*, Yedi Pu^2*, Juanxia Meng^2*, Xiaomei Zhang^3*, Haibo Zhu^2*, Ting Yuan^2*, Bing Wang^2*, Xin Jin, MD^2*, Xinping Cao^2*, Zhao Wang^2*, Tianle Xie^2*, Haotian Meng^2*, Alexey Stepanov^4*, Alexander G. Gabibov^5*, Yuxin An, MD^2*, Rui Sun^3*, Yu Zhang^2*, Mikhail A. Maschan^6*, Zunmin Zhu, MD, PhD^7*, Hongkai Zhang^8* and Mingfeng Zhao²

¹Henan Provincial People’s Hospital, Zhengzhou, China
²Tianjin First Central Hospital, Tianjin, China
³Medical School of Nankai University, Tianjin, China
⁴M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia, Moscow, RUS
⁵M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry of the Ru, Moscow, RUS
⁶Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia, Moscow, Russian Federation
⁷Department of Hematology, Henan Provincial People’s Hospital, Zhengzhou, China
⁸State Key Laboratory of Medicinal Chemical Biology and College of Life Science,, Tianjin, CHN

Madhav V. Dhodapkar, MD, PhD¹, Melissa Alsina, MD^2*, Jesus G. Berdeja, MD³, Krina K. Patel, MD, MSc⁴, Shambavi Richard, MD⁵, Ravi Vij, MD, MBA⁶, Xavier Leleu, MD⁷, Daniel N. Egan, MD⁸, P. Leif Bergsagel, MD⁹, Ran Reshef, MD, MSc¹⁰, Saad Z Usmani, MD¹¹, Anna Truppel-Hartmann, MD^12*, Debashree Basudhar^13*, Ethan Thompson, PhD^13*, Xirong Zheng^14*, Laurie Eliason, MPH^13*, Xiaobo Zhong^13*, Chiara Greggio^15*, Sinhan Tran^13*, Maria Chaudhry^13*, Marlene J. Carrasco-Alfonso^13* and David S. Siegel, MD, PhD¹⁶

¹Winship Cancer Institute of Emory University, Atlanta
²Moffitt Cancer Center, Tampa, FL
³Sarah Cannon Research Institute, Nashville, TN
⁴MD Anderson Cancer Center, Houston, TX
⁵Mount Sinai Hospital, New York, NY
⁶Washington University St. Louis, St Louis, MO
⁷CHU La Milétrie, Poitiers, France
⁸Swedish Center for Blood Disorders and Stem Cell Transplants, Seattle, WA
⁹Mayo Clinic Arizona, Phoenix, AZ
¹⁰Columbia University Irving Medical Center, New York
¹¹Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹²2seventy bio, Cambridge, MA
¹³Bristol Myers Squibb, Princeton, NJ
¹⁴Clinical Pharmacology, Pharmacometrics, Disposition & Bioanalysis, Bristol Myers Squibb, Princeton, NJ
¹⁵Bristol Myers Squibb, Boudry, Switzerland
¹⁶Hackensack University John Theurer Cancer Center, Hackensack, NJ

Mazyar Shadman, MD, MPH¹, Paolo F. Caimi, MD², Susan M. O'Brien³, Patrick M. Reagan, MD⁴, Bruce Dezube, MD⁵, Punya Navaratnarajah, PhD^5*, Tripti Gaur, PhD^5*, Suzanne Petrossian, MS^5*, Anthony Germani, BS^1*, Brian G Till¹ and Jeremy S. Abramson, MD⁶

¹Fred Hutchinson Cancer Center, Seattle, WA
²Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
³Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA
⁴Wilmot Cancer Institute, University of Rochester Medical Center, Fairport, NY
⁵Mustang Bio, Worcester, MA
⁶Massachusetts General Hospital Cancer Center, Boston, MA

Gabriela S. Hobbs, MD¹, Haesook T. Kim, PhD², Suzanne O'Connor^3*, Mark A. Schroeder, MD⁴, Roni Tamari, MD^5*, Sarah A Wall, MD, MPH⁶, Areej El-Jawahri, MD³, Steven McAfee, MD^3*, Jessica Hem^7*, Patricia Lozano^8*, Jonas S. Jutzi, MD, PhD⁹, Ann Mullally, MD¹⁰, Yi-Bin Chen, MD, MS³ and Zachariah Defilipp, MD³

¹Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA
²Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
³Massachusetts General Hospital, Boston, MA
⁴Division of Oncology, Washington University School of Medicine, Saint Louis, MO
⁵Memorial Sloan Kettering Cancer Center, New York, NY
⁶Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
⁷Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
⁸Einstein Medical School, New York, NY
⁹Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA
¹⁰Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA

Sharat Damodar, MBBS, MD, DM^1*, Sunil Bhat, MD^1*, Raja Thirumalairaj, MD DM^2*, Pankaj Malhotra, MD³, Akshatha Nayak, MD^1*, Pooja Mallya, MD^1*, Ravi Joshi, MD^1*, Revathy Raj, MD^2*, Rameez Ahamed, MD^2*, Charanpreet Singh, MD, MBBS, DM^3*, Deepak MB, MD^1*, Sudarshan Chougule, MD^1*, Lakshman Vaidhyanathan, MD^2*, Man Updesh Singh Sachdeva, MD^3*, Karthik GA, MD^1*, Sunil HV, MD^1*, Jayaraj Govindaraj, MD^2*, Shelley Simon, MD^2*, Rajender Kumar Basher, MD^3*, Sudeshna Dhar^4*, Arun Kumar MG^4*, Pallavi Arasu^4*, Sri Ramulu Elluru^4*, Mohammed Manzoor Akheel, MPH MBA^4* and Anil Kamat, MD FRCP FRCPath MBA⁴

¹Mazumdar Shaw Medical Centre, Narayana Health City, Bengaluru, India
²Apollo Speciality Hospital, Chennai, India
³Postgraduate Institute of Medical Education and Research, Chandigarh, India
⁴Immuneel Therapeutics Private Limited, Bengaluru, India

Grace Caroline Birch, PhD^1*, Juliana Vergara-Cadavid, MD, Msc^2*, Mohsin Maqbool, PhD^3*, Alba Martini^3*, Khanlinh Dinh, Bsc^3*, Roman M. Shapiro, MD⁴, Michela Ansuinelli, MD^4,5*, Tuyet Nguyen^3*, Carol Reynolds, PhD^4*, Im Soo Y^6*, Hope Wei^3*, Sarah Hogan^3*, Elizabeth Kendricken, BSN, RN^6*, Adam S. Sperling, MD, PhD^4,7, Omar Nadeem, MD^4,8, Jacob Laubach⁹, Alissa Rybicki^10*, Steven Schnittman, MD^11*, Elyse Stock, MD^12*, Diego Hernandez Rodriguez^3*, Heather Daley^4*, Sarah Nikiforow, MD, PhD⁴, Jerome Ritz, MD⁵, Robert J. Soiffer, MD⁵, Giada Bianchi, MD^{4,5,7,13,14,15} and Rizwan Romee, MD^{1,4,7,16,17,18,19}

¹Dana Farber Cancer Institute, Boston, MA
²Dana Farber Cancer Institute, Boston
³DFCI, Boston
⁴Dana-Farber Cancer Institute, Boston, MA
⁵Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁶DFCI, Boston, MA
⁷Harvard Medical School, Boston, MA
⁸Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA
⁹Dana-Farber/Partners CancerCare, Harvard Medical School, Boston, MA
¹⁰Bristol-Myers Squibb, Wallingford, CT
¹¹Biohaven, New Haven, CT
¹²Biohaven, New haven, CT
¹³Amyloidosis Program, Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA
¹⁴Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹⁵Division of hematology, Brigham and Women's Hospital, Boston
¹⁶Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
¹⁷Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA
¹⁸Brigham & Women's Hospital, Boston, MA
¹⁹Dana Farber / Harvard Medical School, Boston, MA

Xiaomei Zhang^1*, Hairong Lv^2*, Xia Xiao, MD^2*, Xue Bai^2*, Pengjiang Liu^2*, Yedi Pu^2*, Juanxia Meng^2*, Haibo Zhu^2*, Zhao Wang^2*, Huan Zhang^2*, Yu Zhang^2*, Cuicui Lv^2*, Li Ma^2*, Ting Yuan^2*, Meng Zhang^2*, Rui Sun^1*, Yifan Zhao^2*, Xinping Cao^2*, Ruiting Guo^2*, Yi Zhang^2*, Shujing Guo^2*, Jile Liu^2* and Mingfeng Zhao, MD, PhD^1,2

¹Medical School of Nankai University, Tianjin, China
²Tianjin First Central Hospital, Tianjin, China

Xian Zhang, MD^1,2*, Lin Wang^3*, Junfang Yang^4,5*, Jingjing Li^4,5*, Hongxing Liu^4,5, Jianqiang Li, PhD^6* and Peihua Lu, MD^2,7*

¹Beijing Lu Daopei Hospital, Beijing, China
²Department of Hematology, Hebei Yanda Lu Daopei Hospital, Langfang, China
³Hebei Senlang Biotechnology, Shijiazhuang, China
⁴Beijing Lu Daopei Institute of Hematology, Beijing, China
⁵Hebei Yanda Lu Daopei Hospital, Langfang, China
⁶Hebei Senlang Biotechnology Co., Ltd., Shijiazhuang, China
⁷Beijing Lu Daopei Institute of Hematology, Langfang, China

Biao Zheng, MD, PhD¹, Yongxian Hu^2,3,4,5*, Jiqin Zhang, PhD^1*, Mingming Zhang^2,3,4,5*, Wei Li, PhD^1*, Wenjun Wu, MD^2,3,4,5*, Jiazhen Cui^2,3,4,5*, Guoqing Wei^2,4,5,6*, Bing Du, MD, PhD^1,7*, Mingyao Liu, MD, PhD^1,7* and He Huang^2,3,4,5*

¹BRL Medicine Inc., Shanghai, China
²Institute of Hematology, Zhejiang University, Hangzhou, China
³Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁴Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China
⁵Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China
⁶Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁷Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China

Fang Liu, MD^1*, Ye Guo, MD^2*, Wenyu Yang^3*, Ying Wang^4* and Xiaofan Zhu, MD^5*

¹Pediatric Blood Diseases Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, AL, China
²State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
³Pediatric Blood Diseases Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China
⁴State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, CHN
⁵State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China

Jeremy S. Abramson, MD¹, Aravind Ramakrishnan, M.D.², Ana Alfonso Pierola, M.D., Ph.D.^3*, Ira Braunschweig, M.D.^4*, Guillaume Cartron, MD, Ph-D^5*, Catherine Thieblemont, MD^6*, Jose A. Pérez-Simón⁷, Pere Barba, MD⁸, Peter A. Riedell, MD⁹, Carlos Solano, MD, PhD¹⁰, Thomas Gastinne, MD^11*, Alexandra LaCroce^12*, Denise Thomas, M.Sc.^12*, Camille Poirot, Pharm.D.^12*, Sarah Meadows, Ph.D.^12*, Kathryn J. Newhall, PhD^12*, Daniel J. Lee, MD¹², Mark G. Frattini, MD, PhD¹² and Emmanuel Bachy, MD, PhD^13*

¹Massachusetts General Hospital Cancer Center, Boston, MA
²Sarah Cannon Transplant and Cellular Therapy Program at St. David's South Austin Medical Center, Austin, TX
³Department of Oncology-Hematology, Centro de Investigación Médica Aplicada (CIMA). Navarra university-IDISNA. Centro de Investigación Biomédica en Red de Cáncer, CIBERONC. Clínica Universidad de Navarra, Pamplona, Spain
⁴Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
⁵Centre Hospitalier Universitaire de Montpellier, Montpellier, France
⁶Hopital Saint-Louis, Paris, France
⁷Hospital Universitario Virgen del Rocío, Sevilla, Spain
⁸Deparment of Hematology, Vall Hebron Institute of Oncology (VHIO), Hospital Universitari Vall D'Hebron, La Garriga, Barcelona, Spain
⁹Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
¹⁰Hematology Department, Hospital Clínico Universitario-INCLIVA, Valencia, Spain
¹¹CHU de Nantes, Nantes, France
¹²Cellectis, Inc., New York, NY
¹³Clinical Hematology, Hospices Civils de Lyon and Claude Bernard Lyon 1 University, Lyon, France

Yongxian HU^1*, Guoqing Wei^2*, Shan Fu^3*, Pingnan Xiao^3*, Jingjing Feng, MD^4*, Mingming Zhang^3*, Xingbing Wang, MD^5*, Dongrui Wang^3*, Jun Li^6* and He Huang^3*

¹Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, HANGZHOU, AL, China
²Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
³Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁴The First affiliated Hospital, School of Medicine, Hangzhou, China
⁵The Flirst Affiliated Hospital Of University of Science and Technology of China, Hefei, Anhui, CHN
⁶Fundamenta Therapeutics Co., Ltd., Suzhou, China

Natalia Tovar^1*, Valentin Ortiz-Maldonado, MD^2*, Nuria Martinez-Cibrian, MD^1*, Sergi Betriu^1*, Daniel Esteban^1*, Ana Triguero^1*, Nadia Verbruggen^3*, Maike Spoon^4*, Marte C. Liefaard^4*, Margot Pont^4* and Anna D.D. van Muyden^4*

¹Hospital Clínic de Barcelona, Barcelona, Spain
²Hospital Clinic, Barcelona, Spain
³Galapagos NV, Mechelen, Belgium
⁴CellPoint BV, a Galapagos company, Oegstgeest, Netherlands

Marie José Kersten, MD, PhD¹, Kirsten Saevels^2*, Yves Beguin^3*, Joost S.P Vermaat, MD, PhD, MSc⁴, Nadia Verbruggen^5*, Maike Spoon^6*, Marte C. Liefaard^6*, Margot Pont^6*, Anna D.D. van Muyden^6*, Maria T. Kuipers^1* and Sébastien Anguille^2*

¹Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
²Antwerp University Hospital, Antwerp, Belgium
³Centre Hospitalier Universitaire de Liège, Liège, Belgium
⁴Leiden University Medical Center, Leiden, Netherlands
⁵Galapagos NV, Mechelen, Belgium
⁶CellPoint BV, a Galapagos company, Oegstgeest, Netherlands

Claire Roddie, MD, PhD^1*, Eleni Tholouli, MD, PhD^2*, Paul Shaughnessy, MD^3*, Elias Jabbour⁴, Aaron C. Logan, MD, PhD⁵, Katharine Hodby, PhD^6*, Luke Mountjoy, DO^7*, Adrian John Clifton Bloor, PhD, FRCPath, FRCP^8*, David Irvine, FRCPath, PhD^9*, David C. Linch, MD^10*, Kim H. Orchard, MBBS, PhD, FRCP, FRCPath^11*, William Wilson^12*, Bilyana Popova, MSc^13*, Juliana Dias, PhD^14*, Giulia Agliardi, PhD^15*, Victoria Spanswick, PhD^16*, Helen Lowe, PhD^17*, Marina Mitsikakou, MRes^18*, Eftychia Charalambous, MSc^19*, Joanna Dawes, PhD^20*, Meera Raymond, PhD^20*, Yanqing Hu, PhD^20*, Wolfram Brugger, MD, PhD²¹, Martin A. Pule, MD^20*, Jae H. Park, MD²² and Karl Peggs, MD^23*

¹Research Department of Haematology, University College London Cancer Institute, London, United Kingdom
²Department of Haematology, Manchester Royal Infirmary, Manchester, United Kingdom
³Methodist Hospital, San Antonio, TX
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, University of California at San Francisco, San Francisco, CA
⁶University Hospital Bristol, Bristol, United Kingdom
⁷Colorado Blood Cancer Institute, Denver, CO
⁸Haematology and Transplant Unit, Christie NHS Foundation Trust, Manchester, United Kingdom
⁹Stem cell transplant and Cell Therapy unit, Queen Elizabeth University Hospital, Glasgow, United Kingdom
¹⁰Department of Haematology, Royal Free and University College London Medical School, London, United Kingdom
¹¹University Hospital Southampton, Southampton, United Kingdom
¹²Cancer Research UK & UCL Cancer Trials Centre, University College London Cancer Institute, London, United Kingdom
¹³Cancer Research UK & UCL Cancer Trials Centre, London, United Kingdom
¹⁴University College London and Centre for Cell Gene and Tissue Therapeutics, Royal Free Hospital NHS Foundation, Research Department of Haematology, London, United Kingdom
¹⁵Royal Free Hospital, Research Department of Haematology, UCL Cancer Institute, London, United Kingdom
¹⁶UCL ECMC GCLP Facility, University College London Cancer Institute, London, United Kingdom
¹⁷UCL ECMC GCLP Facility, UCL Cancer Institute, London, United Kingdom
¹⁸Haematology Department, UCL Cancer Institute, London, United Kingdom
¹⁹Research Department of Haematology, UCL Cancer Institute, London, United Kingdom
²⁰Autolus Therapeutics, London, United Kingdom
²¹Autolus Therapeutics, Munich, Germany
²²Memorial Sloan Kettering Cancer Center, New York, NY
²³Haematology Department, UCLH, London, United Kingdom

Ping Li^1*, Wei Liu, MD^2*, Shiguang Ye, MD^1*, Lili Zhou^1*, Judy Zhu, MD^3*, Jiaqi Huang, MD, PhD^3*, Jing Li, MD^3*, Shigui Zhu, PhD^3*, Chengxiao Zheng, MD^3*, Kevin Zhu, BS^4*, Xin Yao, PhD^3*, Hui Wan, MD, PhD^3*, Yihong Yao, PhD⁵, Aibin Liang, MD, PhD^1* and Dehui Zou^6*

¹Department of Hematology, Tongji Hospital of Tongji University, Shanghai, China
²State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
³Cellular Biomedicine Group Inc., Shanghai, China
⁴University of Maryland, School of Medicine, Baltimore
⁵Cellular Biomedicine Group Inc., Gaithersburg, MD
⁶Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Yuhan Yan^1*, Yixuan Tu^1*, De-Pei Wu² and Xin Li^3*

¹The Third Xiangya Hospital of Central south University, Changsha, China
²Department of Hematology, Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, the First Affiliated Hospital of Soochow University, Suzhou, China
³Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, China

Ma Chao, MD^1*, Liu Daihong, MD^2* and Liping Dou, MD²

¹Chinese PLA General Hospital, Beijing, China
²Chinese PLA General Hospital, Beijing, CHN